Quarterly report pursuant to Section 13 or 15(d)

COMMON SHARES (Tables)

v3.22.1
COMMON SHARES (Tables)
 9 Months Ended
Mar. 31, 2022
SHAREHOLDERS' EQUITY  
schedule for the Company's outstanding non-qualified stock options:

 

 

Number of options

 

Weighted average

exercise price

 

Outstanding, June 30, 2021

 

 

 -

 

 

 USD

 -

 

Granted

 

 

 6,000,000

 

 

 USD

 0.65

 

Exercised

 

 

 -

 

 

 USD

 -

 

Cancelled

 

 

 -

 

 

 USD

-

 

Outstanding, March 31, 2021

 

 

 6,000,000

 

 

 USD

 0.65

 
Schedule of stock options outstanding:

Grant Date

 

Number

Outstanding

 

 

Number

Exercisable

 

Exercise

Price

 

Weighted Average

Life (years)

 

 

Expiry Date

  

January 3, 2022

 

 

 125,000

 

 

 

 -

 

USD

 0.65

 

 

 9.77

 

 

January 3, 2032

  

January 4, 2022

 

 

 5,875,000

 

 

 

 -

 

USD

0.65

 

 

 9.77

 

 

January 4, 2032

  

Total

 

 

 6,000,000

 

 

 

 -

 

USD

0.65

 

 

 9.77

 

 

 

  
schedule for the Company's outstanding warrants:

 

 

Number of Warrants

 

 

Weighted

 Average

Exercise Price

 

Outstanding, June 30, 2021

 

 

 3,014,246

 

 

 $ 0.25

 

Granted

 

 

 -

 

 

 

 -

 

Exercised

 

 

 -

 

 

 

 -

 

Expired

 

 

 -

 

 

 

 -

 

Outstanding, March 31, 2022

 

 

 3,014,246

 

 

 $ 0.25

 
schedule for the Company's outstanding performance stock units:

 

 

Number of Options

 

 

Weighted

Average

 Exercise Price

 

Outstanding, June 30, 2021

 

 

 -

 

 

 $ -

 

Granted

 

 

 4,000,000

 

 

 

 -

 

Released

 

 

 -

 

 

 

 -

 

Forfeited or cancelled

 

 

 -

 

 

 

 -

 

Outstanding, March 31, 2022

 

 

 4,000,000

 

 

 $ -

 
Schedule of weighted average assumptions:

Expected volatility

 

 

 106.83 %

Expected option life (years)

 

 

 10

 

Risk-free interest rate (10-year U.S. treasury yield)

 

1.63 - 1.66

 %

Expected dividend yield

 

 

 0 %